Profile
John D.
Suliman is Chief Financial Officer at Shape Therapeutics, Inc. since 2018.
Formerly, Mr. Suliman worked as a Research Associate at Sands Capital Management LLC and as an Analyst at Jefferies LLC from 2005 to 2006.
Mr. Suliman completed undergraduate studies at Georgetown University in 2007.
John Suliman active positions
| Companies | Position | Start |
|---|---|---|
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Director of Finance/CFO | 01/04/2018 |
Former positions of John Suliman
| Companies | Position | End |
|---|---|---|
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/08/2006 |
Sands Capital Management LLC
Sands Capital Management LLC Investment ManagersFinance Sands Capital employs fundamental, bottom-up, and company-focused research in their investment process. The firm identifies and invests in high-quality businesses that can generate sustainable, above-average earnings growth over time, globally. The strategies they offer are typified by deep, proprietary, business-focused global research, concentration, and a long-term investment horizon. | Analyst-Equity | - |
Training of John Suliman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sands Capital Management LLC
Sands Capital Management LLC Investment ManagersFinance Sands Capital employs fundamental, bottom-up, and company-focused research in their investment process. The firm identifies and invests in high-quality businesses that can generate sustainable, above-average earnings growth over time, globally. The strategies they offer are typified by deep, proprietary, business-focused global research, concentration, and a long-term investment horizon. | Finance |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
- Stock Market
- Insiders
- John Suliman
















